So, the first step toward success involves creating a ... I’ve never yet encountered a drug development organization that doesn’t want to be successful. However, many fail to recognize that ...

The agency is missing deadlines and not responding to biotech companies, forcing some to push back clinical trials.

In recent weeks, biotech companies have faced setbacks in moving forward with clinical trials due to operational delays at the FDA, according to an exclusive report from The Wall Street Journal ...

“This is a really exciting new area that has tremendous potential to assist drug discovery and development,” says Koguchi. “It’s creating new avenues of research that were never before ...

In a landmark decision poised to revolutionize drug development, the U.S. Food and Drug Administration (FDA) has announced a ...

Traditionally, hybridoma technology — a five-step process based on the fusion ... including antibody drug development. The single cells flow one by one in the droplets, while the testing and ...

Furthermore, the high costs of in-house drug development have also contributed to this trend. Industry players are likely to witness healthy growth opportunities due to the technological ...